Viewing Study NCT04511702


Ignite Creation Date: 2025-12-25 @ 3:49 AM
Ignite Modification Date: 2026-02-09 @ 12:11 AM
Study NCT ID: NCT04511702
Status: COMPLETED
Last Update Posted: 2025-10-17
First Post: 2020-08-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Uncontrolled Gout View
None Gout View
None Uncontrolled Gout View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gout View
None uncontrolled gout View